Sign in

CIK 0001469443

  • Non-accelerated filer
  • Smaller reporting company

Arcadia Biosciences, Inc.

Sign in to watch
Ticker
RKDA
Exchange
Nasdaq
Industry
Beverages
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810571538
Phone
+1 214-974-8921
Business address
5956 SHERRY LANE, SUITE 2000, DALLAS, TX
  1. 4 Open-market buy Chief Technology Officer bought 700 shares at $3.16 ($2,212)
  2. 4 Open-market buy Chief Financial Officer bought 700 shares at $3.16 ($2,212)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Chief Financial Officer bought 700 shares at $1.72 ($1,204)
  13. 4 Open-market buy Chief Commercial Officer bought 700 shares at $1.72 ($1,204)
  14. 4 Open-market buy Chief Executive Officer bought 700 shares at $1.72 ($1,204)
  15. 4 Open-market buy Chief Commercial Officer bought 900 shares at $5.95 ($5,355)
  16. 4 Open-market buy Chief Commercial Officer bought 1,000 shares at $4.52 ($4,520)
  17. 4 Open-market buy Director bought 5,000 shares at $4.25 ($21,250)
  18. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.08 ($4,080)
  19. 4 Open-market buy Chief Executive Officer bought 2,000 shares at $5.25 ($10,500)
  20. 4 Open-market buy Director bought 5,000 shares at $5.88 ($29,388)

Page 4 of 11 · 203 filings